Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver

Cited by (407)

Items 101–200 of 407

1. Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans
   Manoj Amrutkar, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Emmelie Cansby, Urszula Chursa, Elin Stenfeldt, Jan Borén, Matthias Blüher, Margit Mahlapuu · 2015 · Diabetologia
2. Targeted Expression of Catalase to Mitochondria Protects Against Ischemic Myopathy in High-Fat Diet–Fed Mice
   TERENCE EDWARD RYAN, Cameron A. Schmidt, Thomas D. Green, Espen E. Spangenburg, Peter Darrell Neufer, Joseph M. McClung · 2016 · Diabetes
3. Translational approaches: from fatty liver to non-alcoholic steatohepatitis.
   Natalia Rosso, Norberto Carlos Chávez-Tapia, Claudio Tiribelli, Stefano Bellentani · 2014 · PubMed Central
4. Mitochondria-associated ER membranes in glucose homeostasis and insulin resistance
   Logan K. Townsend, Henver S. Brunetta, Marcelo A. Mori · 2020 · American Journal of Physiology-Endocrinology and Metabolism
5. Approach to assessing determinants of glucose homeostasis in the conscious mouse
   Curtis C. Hughey, David H. Wasserman, Robert S. Lee, Louise Lantier · 2014 · Mammalian Genome
6. Sex modulates hepatic mitochondrial adaptations to high-fat diet and physical activity
   Colin S. McCoin, Alex T. Von Schulze, Julie Allen, Kelly N. Z. Fuller, Qing Xia, Devin C. Koestler, Claire J. Houchen, Adrianna Maurer, Gerald W. Dorn, Kartik Shankar et al. · 2019 · American Journal of Physiology-Endocrinology and Metabolism
7. Urinary Loss of Tricarboxylic Acid Cycle Intermediates As Revealed by Metabolomics Studies: An Underlying Mechanism to Reduce Lipid Accretion by Whey Protein Ingestion?
   Haldis H. Lillefosse, Morten Rahr Clausen, Christian Clement Yde, Ditte B. Ditlev, Xumin Zhang, Zhen‐Yu Du, Hanne Christine Bertram, Lise Madsen, Karsten Kristiansen, Bjørn Liaset · 2014 · Journal of Proteome Research
8. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
   Michelle L. Boland, Stephanie N. Oldham, Brandon B. Boland, Sarah Will, Jean‐Martin Lapointe, Silvia Guionaud, Christopher J. Rhodes, James L. Trevaskis · 2018 · World Journal of Gastroenterology
9. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis
   Srilaxmi Kalavalapalli, Fernando Bril, Joy Guingab, Ariana Vergara, Timothy J. Garrett, Nishanth E. Sunny, Kenneth J. Cusi · 2019 · Journal of Endocrinology
10. Integrin α1-null Mice Exhibit Improved Fatty Liver When Fed a High Fat Diet Despite Severe Hepatic Insulin Resistance
    Ashley S. Williams, Li Kang, Jenny Zheng, Carrie A. Grueter, Deanna P. Bracy, Freyja D. James, Ambra Pozzi, David H. Wasserman · 2015 · Journal of Biological Chemistry
11. Improved experimental data processing for UHPLC–HRMS/MS lipidomics applied to nonalcoholic fatty liver disease
    Rainey E. Patterson, Alexander Kirpich, Jeremy P. Koelmel, Srilaxmi Kalavalapalli, Alison M. Morse, Kenneth J. Cusi, Nishanth E. Sunny, Lauren M. McIntyre, Timothy J. Garrett, Richard A. Yost · 2017 · Metabolomics
12. Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism
    Guo-En Wang, Yi-Fang Li, Yu-Jia Zhai, Lian Gong, Jingyu Tian, Mo Hong, Nan Yao, Yanping Wu, Hiroshi Kurihara, Rong‐Rong He · 2018 · Metabolism
13. Nutrient sensing by the mitochondrial transcription machinery dictates oxidative phosphorylation
    Lijun Liu, Minwoo Nam, Wei Fan, Thomas E. Akie, David C. Hoaglin, Guangping Gao, John F. Keaney, Marcus P. Cooper · 2014 · Journal of Clinical Investigation
14. Berberine Reduces Pyruvate-driven Hepatic Glucose Production by Limiting Mitochondrial Import of Pyruvate through Mitochondrial Pyruvate Carrier 1
    Aiyun Li, Qun Liu, Qiang Li, Baolin Liu, Yang Yang, Ning Zhang · 2018 · EBioMedicine
15. Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates
    Stephanie R. Wesolowski, C. Mulligan, R. Janssen, Peter R. Baker, B. Bergman, A. D'Alessandro, T. Nemkov, K. Maclean, Hua Jiang, T. Dean et al. · 2018 · Molecular Metabolism
16. A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance
    Raffaella Crescenzo, Francesca Bianco, Arianna Mazzoli, Antonia Giacco, Giovanna Liverini, Susanna Iossa · 2015 · European Journal of Nutrition
17. Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism
    Jorge C. Correia, Julie Massart, Jan Freark de Boer, Margareta Porsmyr‐Palmertz, Vicente Martínez-Redondo, Leandro Z. Agudelo, Indranil Sinha, David Meierhofer, Vera Ribeiro, Marie Björnholm et al. · 2015 · Molecular Metabolism
18. Insulin‐resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria?
    Alessandro Rossi, Margherita Ruoppolo, Pietro Formisano, Guglielmo R.D. Villani, Lucia Albano, Giovanna Gallo, Daniela Crisci, Augusta Moccia, Giancarlo Parenti, Pietro Strisciuglio et al. · 2018 · Journal of Inherited Metabolic Disease
19. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
    Kun Li, Bao Lu Zhao, Diandian Wei, Wenrui Wang, Yixuan Cui, Lisheng Qian, Guodong Liu · 2019 · International Journal of Molecular Medicine
20. Omega-3 polyunsaturated fatty acids prevent obesity by improving tricarboxylic acid cycle homeostasis
    Run Liu, Lei Chen, Zhen Wang, Xuewei Zheng, Zhanwu Hou, Daina Zhao, Jiangang Long, Jiankang Liu · 2020 · The Journal of Nutritional Biochemistry
21. Functional metabolomics using UPLC-Q/TOF-MS combined with ingenuity pathway analysis as a promising strategy for evaluating the efficacy and discovering amino acid metabolism as a potential therapeutic mechanism-related target for geniposide against alcoholic liver disease
    Shi Qiu, Aihua Zhang, Yu Guan, Hui Juan Sun, Tianlei Zhang, Ying Han, Guangli Yan, Xijun Wang · 2020 · RSC Advances
22. In Vivo Estimates of Liver Metabolic Flux Assessed by 13C-Propionate and 13C-Lactate Are Impacted by Tracer Recycling and Equilibrium Assumptions
    Clinton M. Hasenour, Mohsin Rahim, Jamey D. Young · 2020 · Cell Reports
23. AMPK mediates energetic stress‐induced liver GDF15
    Logan K. Townsend, Alyssa J. Weber, Emily Anne Day, Hesham Shamshoum, Simon J. Shaw, Christopher G. R. Perry, Bruce E. Kemp, Gregory R. Steinberg, David Charles Wright · 2020 · The FASEB Journal
24. Nutrients, Physical Activity, and Mitochondrial Dysfunction in the Setting of Metabolic Syndrome
    Gabriela Lemos, Raquel Susana Torrinhas, Dan Linetzky Waitzberg · 2023 · Nutrients
25. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids
    Sonia Garcia‐Caraballo, Tine M. Comhair, Sander M. Houten, Cornelis H.C. Dejong, Wouter H. Lamers, Eleonore S Köhler · 2014 · The Journal of Nutritional Biochemistry
26. The longevity gene INDY ( I 'm N ot D ead Y et) in metabolic control: Potential as pharmacological target
    Diana M. Willmes, Anica Kurzbach, Christine Henke, Tina Schumann, Grit Zahn, Alexander Heifetz, Jens Jordan, Stephen L. Helfand, Andreas L. Birkenfeld · 2017 · Pharmacology & Therapeutics
27. Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Raghu Ramanathan, Sohum A. Patwa, Ahmad Hassan Ali, Jamal A. Ibdah · 2023 · Cells
28. Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidence
    Dorothy A. Kieffer, Valentina Medici · 2017 · Liver Research
29. Metabolic alterations in triptolide‐induced acute hepatotoxicity
    Jie Zhao, Cen Xie, Xiyan Mu, Kristopher W. Krausz, Daxesh P. Patel, Xiaowei Shi, Xiaoxia Gao, Qiao Wang, Frank J. Gonzalez · 2018 · Biomedical Chromatography
30. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance
    Lia R. Edmunds, Bingxian Xie, Amanda M. Mills, Brydie R. Huckestein, Ramya Undamatla, Anjana Murali, Martha M. Pangburn, James L. Martin, IAN J. SIPULA, Brett A. Kaufman et al. · 2020 · Molecular Metabolism
31. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
    Xiaoli Pan, Yanqiao Zhang · 2022 · Chinese Medical Journal
32. An Investigation into the Antiobesity Effects ofMorinda citrifoliaL. Leaf Extract in High Fat Diet Induced Obese Rats Using a1H NMR Metabolomics Approach
    Najla Gooda Sahib, Nazamid Saari, Amin Ismail, Alfi Khatib, Mohamad Fawzi Mahomoodally, Azizah Abdul Hamid · 2015 · Journal of Diabetes Research
33. Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
    Marcus J. Lyall, Jessy Cartier, John P. Thomson, Kate Cameron, Jose Meseguer-Ripolles, Eoghan O’Duibhir, Dagmara Szkolnicka, Baltasar Lucendo‐Villarin, Yu Wang, Giovanny Rodriguez Blanco et al. · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
34. Mitochondrial Dysfunction and Acute Fatty Liver of Pregnancy
    Raghu Ramanathan, Jamal A. Ibdah · 2022 · International Journal of Molecular Sciences
35. Influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice
    Marumi Ohno, Toshiki Sekiya, Naoki Nomura, Taku ji Daito, Masashi Shingai, Hiroshi Kida · 2020 · Scientific Reports
36. Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
    Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
37. Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
    Yifei Chen, Fuji Yang, Ying Chu, Zhihua Yun, Yongmin Yan, Jianhua Jin · 2022 · Journal of Translational Medicine
38. A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis
    Matthew C. Sinton, Jose Meseguer-Ripolles, Baltasar Lucendo‐Villarin, Sara Wernig-Zorc, John P. Thomson, Roderick N. Carter, Marcus J. Lyall, Paul D. Walker, Alpesh Thakker, Richard R. Meehan et al. · 2020 · iScience
39. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis
    E. Matthew Morris, Grace Margaret-Eleanor Meers, Lauren G. Koch, Steven L. Britton, Justin A. Fletcher, Xiaorong Fu, Kartik Shankar, Shawn C. Burgess, Jamal A. Ibdah, R. Scott Rector et al. · 2016 · American Journal of Physiology-Endocrinology and Metabolism
40. Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
    McCommis, Kyle S., Finck, Brian N. · 2019 · Cellular and Molecular Gastroenterology and Hepatology
41. Metabolic flux analysis in Ashbya gossypii using 13C-labeled yeast extract: industrial riboflavin production under complex nutrient conditions
    Susanne Katharina Schwechheimer, Judith Becker, Lindsay Peyriga, Jean‐Charles Portais, Christoph Wittmann · 2018 · Microbial Cell Factories
42. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis
    Effi Haque, M. Rezaul Karim, Aamir Salam Teeli, Magdalena Śmiech, Paweł Leszczyński, Dawid Winiarczyk, Emil D. Parvanov, Atanas G. Atanasov, Hiroaki Taniguchi · 2020 · International Journal of Molecular Sciences
43. Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
    Michael Ezrokhi, Shuqin Luo, Yelena Trubitsyna, Anthony H. Cincotta · 2014 · Diabetology & Metabolic Syndrome
44. Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases
    Madan Kumar Arumugam, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, Lokesh Kumar Boopathy, Sathish Kumar Perumal, Murali Ganesan, Karuna Rasineni, Terrence M. Donohue, Natalia A. Osna, Kusum K. Kharbanda · 2023 · Biology
45. Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States
    Zhi-Qin Xie, Hongxia Li, Wenliang Tan, Lei Yang, Xiaowu Ma, Wenxin Li, Qingbin Wang, Changzhen Shang, Yajin Chen · 2022 · Frontiers in Nutrition
46. Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity
    Blanka Kucejová, João André Gonçalves Duarte, Santhosh Satapati, Xiaorong Fu, Olga Ilkayeva, Christopher B. Newgard, James Brugarolas, Shawn C. Burgess · 2016 · Cell Reports
47. Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis
    E. Matthew Morris, Colin S. McCoin, Julie Allen, Michelle L. Gastecki, Lauren G. Koch, Steven L. Britton, Justin A. Fletcher, Xiarong Fu, Wen‐Xing Ding, Shawn C. Burgess et al. · 2017 · The Journal of Physiology
48. Fasting‐induced liver GADD45β restrains hepatic fatty acid uptake and improves metabolic health
    Jessica Fuhrmeister, Annika Zota, Tjeerd Sijmonsma, Oksana Seibert, Şahika Cıngır Köker, Kathrin V. Schmidt, Nicola Vallon, Roldan M. de Guia, Katharina Niopek, Mauricio Berriel Díaz et al. · 2016 · EMBO Molecular Medicine
49. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD
    Muhammed Shafeekh Muyyarikkandy, Marc McLeod, Meghan Maguire, Rohit Mahar, Nathan Kattapuram, Christine Zhang, Chaitra Surugihalli, Vaishna Muralidaran, Kruthi Vavilikolanu, Clayton E. Mathews et al. · 2020 · The FASEB Journal
50. Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle
    Riku Egami, Toshiya Kokaji, Atsushi Hatano, Katsuyuki Yugi, Miki Eto, Keigo Morita, Satoshi Ohno, Masashi Fujii, Ken‐ichi Hironaka, Saori Uematsu et al. · 2021 · iScience
51. Glutamate–oxaloacetate transaminase activity promotes palmitate lipotoxicity in rat hepatocytes by enhancing anaplerosis and citric acid cycle flux
    Robert A. Egnatchik, Alexandra K. Leamy, Sarah A. Sacco, Yi Ern Cheah, Masakazu Shiota, Jamey D. Young · 2018 · Journal of Biological Chemistry
52. Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention
    Isabela Jesus de Deus, Ana Flávia Martins-Silva, Miliane Martins de Andrade Fagundes, Sílvia Paula-Gomes, Fernanda Guimarães Drummond e Silva, Larissa Leandro da Cruz, Aline Rezende Ribeiro de Abreu, Karina Barbosa de Queiroz · 2023 · Frontiers in Pharmacology
53. Metformin: update on mechanisms of action on liver diseases
    Gaoyi Ruan, Fangquan Wu, Dibang Shi, Hongxia Sun, Fangyan Wang, Changlong Xu · 2023 · Frontiers in Nutrition
54. Mass Spectrometry-Based Metabolomic and Lipidomic Analyses of the Effects of Dietary Platycodon grandiflorum on Liver and Serum of Obese Mice under a High-Fat Diet
    Hye Lin Park, Kab-Tae Park, Edmond Changkyun Park, Seung Ju Kim, Myung Choi, Kwang‐Hyeon Liu, Choong H. Lee · 2017 · Nutrients
55. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease
    Yuchang Li, Liting Chen, Lu Li, Chantal M. Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito et al. · 2021 · iScience
56. Stress signaling and cellular proliferation reverse the effects of mitochondrial mistranslation
    Nicola Ferreira, Kara L. Perks, Giulia Rossetti, Danielle L. Rudler, Laetitia A. Hughes, Judith A. Ermer, Louis H. Scott, Irina Kuznetsova, Tara R. Richman, Vinod K. Narayana et al. · 2019 · The EMBO Journal
57. Fatty acid mimetic PBI-4547 restores metabolic homeostasis via GPR84 in mice with non-alcoholic fatty liver disease
    Jean-Christophe Simard, Jean-François Thibodeau, Martin Leduc, Mikaël Tremblay, Alexandre Laverdure, François Sarra‐Bournet, William Gagnon, Jugurtha Ouboudinar, Liette Gervais, Alexandra Felton et al. · 2020 · Scientific Reports
58. Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice
    Kerstin Lohr, Fiona Pachl, Amin Moghaddas Gholami, Kerstin Elisabeth Geillinger, Hannelore Daniel, Bernhard Küster, Martin Klingenspor · 2016 · Physiological Reports
59. Blood Metabolite Signature of Metabolic Syndrome Implicates Alterations in Amino Acid Metabolism: Findings from the Baltimore Longitudinal Study of Aging (BLSA) and the Tsuruoka Metabolomics Cohort Study (TMCS)
    Jackson A. Roberts, Vijay R. Varma, Chiung-Wei Huang, Yang An, Anup Mammen Oommen, Toshiko Tanaka, Luigi Ferrucci, Palchamy Elango, Toru Takebayashi, Sei Harada et al. · 2020 · International Journal of Molecular Sciences
60. Pcyt2 deficiency causes age-dependant development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphonoethylamine
    Sophie Grapentine, Rathnesh K. Singh, Poulami Basu, Sugashan Sivanesan, Gabriela Ponte de Mattos, Oreoluwa Oresajo, Jasmine Cheema, Wendwesen Demeke, Vernon Wayne Dolinsky, Marica Bakovic · 2022 · Scientific Reports
61. Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD
    Mary P. Moore, Grace E. Shryack, Isabella G. Alessi, Nicole Wieschhaus, Grace Margaret-Eleanor Meers, Sarah A. Johnson, Andrew A. Wheeler, Jamal A. Ibdah, Elizabeth Jane Parks, R. Scott Rector · 2024 · American Journal of Physiology-Endocrinology and Metabolism
62. Tracer-based assessments of hepatic anaplerotic and TCA cycle flux: practicality, stoichiometry, and hidden assumptions
    Stephen F. Previs, David E. Kelley · 2015 · American Journal of Physiology-Endocrinology and Metabolism
63. Pigment Epithelium-Derived Factor (PEDF) Suppresses IL-1β-Mediated c-Jun N-Terminal Kinase (JNK) Activation to Improve Hepatocyte Insulin Signaling
    Arijeet K. Gattu, Andreas L. Birkenfeld, Yasuko Iwakiri, Steven M. Jay, W. Mark Saltzman, Jennifer A. Doll, Petr Protiva, Varman T. Samuel, Susan E. Crawford, Chuhan Chung · 2014 · Endocrinology
64. Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
    Tom Houben, Eelke T. Brandsma, Sofie M. A. Walenbergh, Marten H. Hofker, Ronit Shiri‐Sverdlov · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
65. Increased lipogenesis in spite of upregulated hepatic 5'AMP‐activated protein kinase in human non‐alcoholic fatty liver
    Christian von Loeffelholz, Stephanie Döcke, Johan Friso Lock, Stefanie Lieske, Paul Horn, Jennifer Kriebel, Simone Wahl, Paula Singmann, Tonia de las Heras Gala, Harald Grallert et al. · 2016 · Hepatology Research
66. 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat–high-fructose diet
    Gilles Fouret, Sylvie Gaillet, Jérôme Lecomte, Béatrice Bonafos, Youzan Ferdinand Djohan, Bruno Baréa, Éric Badia, Charles Coudray, Christine Feillet‐Coudray · 2018 · British Journal Of Nutrition
67. Farnesoid X receptor activation induces the degradation of hepatotoxic 1‐deoxysphingolipids in non‐alcoholic fatty liver disease
    Zhibo Gai, Ting Gui, Irina Alecu, Museer A. Lone, Thorsten Hornemann, Qingfa Chen, Michele Visentin, Christian Hiller, Stéphanie Häusler, Gerd Achim Kullak-Ublick · 2019 · Liver International
68. Insulin Sensitivity and Metabolic Flexibility Parallel Plasma TCA Levels in Early Chronotype With Metabolic Syndrome
    Mary‐Margaret E. Remchak, Emily M. Heiston, Anna C. Ballantyne, Brielle L. Dotson, Nathan R. Stewart, Andrea M. Spaeth, Steven K. Malin · 2022 · The Journal of Clinical Endocrinology & Metabolism
69. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
    Stefano Gitto, Giovanni Vitale, Erica Villa, Pietro Andreoné · 2015 · Gastroenterology Research and Practice
70. Simultaneous tracers and a unified model of positional and mass isotopomers for quantification of metabolic flux in liver
    Stanisław Deja, Xiaorong Fu, Justin A. Fletcher, Blanka Kucejová, Jeffrey D. Browning, Jamey D. Young, Shawn C. Burgess · 2019 · Metabolic Engineering
71. Maintenance of liver glycogen during long‐term fasting preserves energy state in mice
    Iliana López‐Soldado, Angelo Bertini, Anna Adrover, Jordi Durán, Joan Josep Guinovart · 2020 · FEBS Letters
72. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability
    Miriam Hoene, Lisa Kappler, Laxmikanth Kollipara, Chunxiu Hu, Martin Irmler, Daniel Bleher, Christoph Hoffmann, Johannes Beckers, Martin Hrabě de Angelis, Hans‐Ulrich Häring et al. · 2021 · Molecular Metabolism
73. A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome
    Zhi-Rui Yu, Yu Ning, Hao Yu, Naijun Tang · 2014 · Journal of Huazhong University of Science and Technology [Medical Sciences]
74. Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
    Joseph W. Gordon, Vernon Wayne Dolinsky, Wajihah Mughal, Grant Robert Gordon, Jonathan McGavock · 2015 · Biochemistry and Cell Biology
75. Genome-Wide Detection of Key Genes and Epigenetic Markers for Chicken Fatty Liver
    Xiaodong Tan, Ranran Liu, Siyuan Xing, Yonghong Zhang, Qinghe Li, Maiqing Zheng, Guiping Zhao, Jie Wen · 2020 · International Journal of Molecular Sciences
76. Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
    Rafael S. Rios, Kenneth I. Zheng, Ming-Hua Zheng · 2021 · Chinese Medical Journal
77. Effect of N-acetyl-l-cysteine on insulin resistance caused by prolonged free fatty acid elevation
    Sandra Pereira, Anu Shah, I. George Fantus, Jamie W. Joseph, Adria Giacca · 2015 · Journal of Endocrinology
78. Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis
    Silvia Sabatini, Partho Sen, Fabrizia Carli, Samantha Pezzica, Chiara Rosso, Erminia Lembo, Ornella Verrastro, Ann K. Daly, Olivier Govaere, Simon Cockell et al. · 2024 · Cell Reports Medicine
79. Sennoside A protects mitochondrial structure and function to improve high-fat diet-induced hepatic steatosis by targeting VDAC1
    Jiamei Le, Weiping Jia, Yongning Sun · 2018 · Biochemical and Biophysical Research Communications
80. Hepatic glucose production pathways after three days of a high-fat diet
    Eunsook S. Jin, Sara A. Beddow, Craig R. Malloy, Varman T. Samuel · 2012 · Metabolism
81. p21-activated kinase 4 suppresses fatty acid β-oxidation and ketogenesis by phosphorylating NCoR1
    Min Yan Shi, Hwang Chan Yu, Chang Yeob Han, In Hyuk Bang, Ho Sung Park, Kyu Yun Jang, Sangkyu Lee, Jeong Bum Son, Nam Doo Kim, Byung‐Hyun Park et al. · 2023 · Nature Communications
82. Ketogenesis supports hepatic polyunsaturated fatty acid homeostasis via fatty acid elongation
    Queathem, Eric D., Moazzami, Zahra, Stagg, David B., Nelson, Alisa B., Fulghum, Kyle, Hayir, Abdirahman, Seay, Alisha, Gillingham, Jacob R., d’Avignon, D. André, Han, Xianlin et al. · 2025 · Science Advances
83. Expansion and Impaired Mitochondrial Efficiency of Deep Subcutaneous Adipose Tissue in Recent-Onset Type 2 Diabetes
    Kálmán Benedikt Bódis, Tomáš Jeleník, Jesper Lundbom, Daniel F. Markgraf, Alexander Strom, Oana‐Patricia Zaharia, Yanislava Karusheva, Volker Burkart, Karsten Müssig, Yuliya Kupriyanova et al. · 2019 · The Journal of Clinical Endocrinology & Metabolism
84. Environmental toxicant-induced maladaptive mitochondrial changes: A potential unifying mechanism in fatty liver disease?
    Regina D. Schnegelberger, Anna L. Lang, Gavin E. Arteel, Juliane I. Beier · 2021 · Acta Pharmaceutica Sinica B
85. Targeting the Metabolic Paradigms in Cancer and Diabetes
    Mira Bosso, Dania Haddad, Ashraf Said Al Madhoun, Fahd Al‐Mulla · 2024 · Biomedicines
86. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
    Esther Nuñez‐Durán, Belén Chanclón, Silva Sütt, Joana I. Real, Hanns–Ulrich Marschall, Ingrid Wernstedt Asterholm, Emmelie Cansby, Margit Mahlapuu · 2017 · Journal of Endocrinology
87. Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation
    Clinton M. Hasenour, D. Emerson Ridley, Freyja D. James, Curtis C. Hughey, E. Patrick Donahue, Benoı̂t Viollet, Marc Foretz, Jamey D. Young, David H. Wasserman · 2017 · PLoS ONE
88. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis
    Atilla Engin · 2024 · Advances in experimental medicine and biology
89. Aqueous Extract of Black Maca Prevents Metabolism Disorder via Regulating the Glycolysis/Gluconeogenesis-TCA Cycle and PPARα Signaling Activation in Golden Hamsters Fed a High-Fat, High-Fructose Diet
    Wenting Wan, Hongxiang Li, Jiamei Xiang, Fan Yi, Lijia Xu, Baoping Jiang, Peigen Xiao · 2018 · Frontiers in Pharmacology
90. Role of Insulin Resistance and Diabetes in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
    Paola Portillo-Sánchez, Sahzene Yavuz, Fernando Bril, Kenneth J. Cusi · 2014 · Current Hepatology Reports
91. Intrinsic High Aerobic Capacity in Male Rats Protects Against Diet-Induced Insulin Resistance
    E. Matthew Morris, Grace Margaret-Eleanor Meers, Gregory N. Ruegsegger, Umesh D. Wankhade, Tommy Robinson, Lauren G. Koch, Steven L. Britton, R. Scott Rector, Kartik Shankar, John P. Thyfault · 2019 · Endocrinology
92. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease
    Inês C. M. Simões, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucińska‐Więckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń et al. · 2019 · Nutrients
93. Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction
    Yuwei Jiang, Jiaoya Xu, Ping Huang, Lili Yang, Yang Liu, Yiping Li, Jue Wang, Haiyan Song, Peiyong Zheng · 2022 · Frontiers in Pharmacology
94. Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
    Sou Hyun Kim, Chawon Yun, Doyoung Kwon, Yun‐Hee Lee, Jae‐Hwan Kwak, Young‐Suk Jung · 2023 · Molecules
95. The impact of blood on liver metabolite profiling – a combined metabolomic and proteomic approach
    Saray Ly-Verdú, Alexander Schäfer, Melanie Kahle, Thomas M. Groeger, Susanne Neschen, Jose Manuel Arteaga-Salas, Marius Ueffing, Martin Hrabě de Angelis, Ralf Zimmermann · 2013 · Biomedical Chromatography
96. Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes
    Marie Holm Solheim, Jonathon N. Winnay, Thiago M. Batista, Anders Molven, Pål R. Njølstad, C. Ronald Kahn · 2018 · Diabetes
97. An Integrated Multi-Omics Study Revealed Metabolic Alterations Underlying the Effects of Coffee Consumption
    Shoko Takahashi, Kenji Saito, Huijuan Jia, Hisanori Kato · 2014 · PLoS ONE
98. Delayed Feeding Alters Transcriptional and Post-Transcriptional Regulation of Hepatic Metabolic Pathways in Peri-Hatch Broiler Chicks
    Julie A. Hicks, Tom E. Porter, Nishanth E. Sunny, Hsiao‐Ching Liu · 2019 · Genes
99. An Integrated Multi-Omics Analysis Defines Key Pathway Alterations in a Diet-Induced Obesity Mouse Model
    Ulrik Kræmer Sundekilde, Christian Clement Yde, A.H. Honoré, Jessica M. Caverly Rae, Frank Burns, Pushkor Mukerji, Michael P. Mawn, Lotta K. Stenman, Yvonne P. Dragan, Kyle Glover et al. · 2020 · Metabolites
100. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity
     Grigorios Papadopoulos, Aigli‐Ioanna Legaki, Konstantina Georgila, Panagiotis A. Vorkas, Eirini Giannousi, George M. Stamatakis, Ioannis I. Moustakas, Maria Petrocheilou, Iryna Pyrina, Bettina Gercken et al. · 2023 · Metabolism